Latest Plasma cell leukemia Stories
HACKENSACK, N.J., Dec.
Scientists at the Institute for Myeloma and Bone Cancer Research (IMBCR) have uncovered a new pathway that could explain how blood vessels form within tumors. LOS ANGELES, Feb.
By Bahat, Gulistan Erten, Nilgun; Saka, Bulent; Uz
When people hear "thalidomide," many think "birth defects," however, evidence has come to light that this once-banned drug can be used as a potent anti-cancer treatment. In a new study, researchers from the University of Bologna, Italy, demonstrate that Thal-Dex (thalidomide used in combination with dexamethasone) is more powerful than conventional chemotherapy for the treatment of multiple myeloma.